IRIDEX Corporation (IRIX) Stock Forecast
IRIX analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $2.75 average of analyst targets
- Upside to target
- +237.6% from the latest close
- Next earnings
- November 10, 2026 EPS estimate $-0.04
- 52-week range
- $0.61 – $1.56
IRIX analyst ratings
1 analystsNumber of analysts at each rating.
IRIX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
IRIX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.04 | −$0.04 | −$0.04 | — | — | 1 |
| Current fiscal year (2026) | −$0.12 | −$0.12 | −$0.12 | −$0.18 | +33.7% | 1 |
| Next fiscal year (2027) | $0.00 | $0.00 | $0.00 | −$0.12 | +100.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
IRIX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $12.6M | $12.6M | $12.6M | — | 1 |
| Current fiscal year (2026) | $52.5M | $52.5M | $52.5M | −0.3% | 1 |
| Next fiscal year (2027) | $56.0M | $56.0M | $56.0M | +6.6% | 1 |
IRIX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
IRIX revenue: reported and forecast
IRIX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.02 | −$0.02 | −$0.02 | −$0.02 | −$0.04 | +100.0% | 0 up · 1 down |
| Current fiscal year (2026) | −$0.05 | −$0.05 | −$0.05 | −$0.05 | −$0.12 | +140.0% | 0 up · 1 down |
| Next fiscal year (2027) | $0.02 | $0.02 | $0.02 | $0.02 | $0.00 | −100.0% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
IRIX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; IRIX beat in 5 of 12.
What analysts expect from IRIX
1 analysts cover IRIDEX; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $2.75, 237.6% above the latest close of $0.81. Analysts expect earnings of −$0.12 per share for 2026, +33.7% from a year earlier. For 2027 the average estimate is $0.00 per share on revenue of $56.0 million. IRIDEX beat the EPS estimate in 5 of the last 12 quarters.
Related: IRIX income statement, IRIX key metrics, IRIX chart. See the IRIX stock overview for the latest quote and news.
IRIX forecast FAQ
What is IRIDEX's price target?
The average analyst price target for IRIDEX is $2.75, 237.6% above the latest close of $0.81.
Is IRIDEX a buy, hold or sell?
Of 1 analysts covering IRIDEX, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is IRIDEX's EPS forecast?
Analysts forecast −$0.12 per share for 2026 (range −$0.12 to −$0.12); for 2027 the estimate is $0.00.
What is IRIDEX's revenue forecast?
The average revenue estimate for 2026 is $52.5 million, growth of −0.3%; for 2027 it is $56.0 million.
When does IRIDEX report earnings?
IRIDEX is expected to report results for the quarter ending September 30, 2026 on November 10, 2026; the EPS estimate is $-0.04.
Does IRIDEX usually beat earnings estimates?
IRIDEX reported EPS at or above the analyst estimate in 5 of the last 12 quarters.